General Information of the Cell Line
Cell Line ID
CL000078
Cell Line Name
T-47D
Synonyms
T-47-D
T47-D
T47D:A
T47D
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0553
Tissue Information
Pleural effusion
Disease
Invasive breast carcinoma of no special type (NCIt: C4194)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01498, 17-beta-hydroxysteroid dehydrogenase type 1
Compound ID Compound Name Compound Formula
CP0396139
(2,6-difluoro-3-hydroxyphenyl)-[5-(4-hydroxyphenyl)thiophen-2-yl]methanone
   Show/Hide
C17H10F2O3S
 1
1
IC50 = 7.9 nM
   TI
   LI
   LO
   TS
CP0148493
(4-fluoro-3-hydroxyphenyl)-(6-hydroxy-1,3-benzothiazol-2-yl)methanone
   Show/Hide
C14H8FNO3S
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0286146
[5-(3-fluoro-4-hydroxyphenyl)thiophen-2-yl]-(3-hydroxyphenyl)methanone
   Show/Hide
C17H11FO3S
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0389067
[4-[5-(2,6-difluoro-3-hydroxybenzoyl)thiophen-2-yl]-2-fluorophenyl] sulfamate
   Show/Hide
C17H10F3NO5S2
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0396140
[2-chloro-4-[5-(2,6-difluoro-3-hydroxybenzoyl)thiophen-2-yl]phenyl] sulfamate
   Show/Hide
C17H10ClF2NO5S2
 1
1
IC50 = 22.2 nM
   TI
   LI
   LO
   TS
CP0387571
2-((8R,9S,13S,14S,16R)-2-ethyl-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-16-yl)-N-(pyridin-3-ylmethyl)acetamide
   Show/Hide
C28H34N2O3
 1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CP0210432
[5-(4-hydroxy-3-methylphenyl)thiophen-2-yl]-(3-hydroxyphenyl)methanone
   Show/Hide
C18H14O3S
 1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CP0084961
3-[[(8R,9S,13S,14S,16R,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide
   Show/Hide
C26H31NO3
 1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CP0159168
(3-hydroxyphenyl)(5-(4-hydroxyphenyl)thiophen-2-yl)methanone
   Show/Hide
C17H12O3S
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0440057
2-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(pyridin-3-ylmethyl)acetamide
   Show/Hide
C26H30N2O3
 1
1
IC50 = 37 nM
   TI
   LI
   LO
   TS
CP0148492
2,6-difluoro-3-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C14H8F2N2O3S
 1
1
IC50 = 37 nM
   TI
   LI
   LO
   TS
CP0485763
[4-[5-(2,6-difluoro-3-hydroxybenzoyl)thiophen-2-yl]-3-fluorophenyl] sulfamate
   Show/Hide
C17H10F3NO5S2
 1
1
IC50 = 42.1 nM
   TI
   LI
   LO
   TS
CP0478318
[3-chloro-4-[5-(2,6-difluoro-3-hydroxybenzoyl)thiophen-2-yl]phenyl] sulfamate
   Show/Hide
C17H10ClF2NO5S2
 1
1
IC50 = 60.9 nM
   TI
   LI
   LO
   TS
CP0134163
3-[[(8R,9S,13S,14S,16R,17S)-3-(2-bromoethyl)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide
   Show/Hide
C28H34BrNO2
 2
1
IC50 = 68 nM
   TI
   LI
   LO
   TS
2
IC50 = 97 nM
   TI
   LI
   LO
   TS
CP0098537
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]methanesulfonamide
   Show/Hide
C23H19NO4S
 1
1
IC50 = 71 nM
   TI
   LI
   LO
   TS
CP0076189
2-fluoro-3-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C14H9FN2O3S
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0243145
[2-(4-hydroxy-3-methylphenyl)-1,3-thiazol-5-yl]-(3-hydroxyphenyl)methanone
   Show/Hide
C17H13NO3S
 1
1
IC50 = 107 nM
   TI
   LI
   LO
   TS
CP0853836
(S)-3-Hydroxy-16-hydroxymethylene-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one
   Show/Hide
C19H22O3
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0053398
1,6-Bis(3-hydroxyphenyl)-2-naphthol
   Show/Hide
C22H16O3
 1
1
IC50 = 115 nM
   TI
   LI
   LO
   TS
CP0278450
[5-(3-chloro-4-hydroxyphenyl)thiophen-2-yl]-(3-hydroxyphenyl)methanone
   Show/Hide
C17H11ClO3S
 1
1
IC50 = 126 nM
   TI
   LI
   LO
   TS
CP0342677
2-fluoro-5-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C14H9FN2O3S
 1
1
IC50 = 152 nM
   TI
   LI
   LO
   TS
CP0395603
3-[[(8R,9S,13S,14S,16R,17S)-3-(3-bromopropyl)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide
   Show/Hide
C29H36BrNO2
 1
1
IC50 = 153 nM
   TI
   LI
   LO
   TS
CP0202860
2-cyano-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C29H20N2O4S
 1
1
IC50 = 157 nM
   TI
   LI
   LO
   TS
CP0162514
6-(3-Hydroxyphenyl)-1-(pyridin-3-yl)-2-naphthol
   Show/Hide
C21H15NO2
 1
1
IC50 = 165 nM
   TI
   LI
   LO
   TS
CP0387939
3-[[(8R,9S,13S,14S,16R,17S)-3-(2-bromoethoxy)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide
   Show/Hide
C28H34BrNO3
 1
1
IC50 = 172 nM
   TI
   LI
   LO
   TS
CP0371772
(S)-6a-Methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthren-2-ol
   Show/Hide
C19H22N2O
 1
1
IC50 = 180 nM
   TI
   LI
   LO
   TS
CP0140150
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H21NO4S
 1
1
IC50 = 196 nM
   TI
   LI
   LO
   TS
CP0054358
6-(3-Hydroxy-phenyl)-naphthalen-2-ol
   Show/Hide
C16H12O2
 1
1
IC50 = 229 nM
   TI
   LI
   LO
   TS
CP0154262
N-[4-[[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]sulfamoyl]phenyl]acetamide
   Show/Hide
C30H24N2O5S
 1
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0309109
3-hydroxy-N-(6-hydroxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C14H10N2O3S
 1
1
IC50 = 245 nM
   TI
   LI
   LO
   TS
CP0154263
2,2,2-trifluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]ethanesulfonamide
   Show/Hide
C24H18F3NO4S
 1
1
IC50 = 246 nM
   TI
   LI
   LO
   TS
CP0086194
(6-hydroxy-1,3-benzothiazol-2-yl)-(3-hydroxy-4-methylphenyl)methanone
   Show/Hide
C15H11NO3S
 1
1
IC50 = 258 nM
   TI
   LI
   LO
   TS
CP0056064
6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol
   Show/Hide
C22H16O2
 1
1
IC50 = 281 nM
   TI
   LI
   LO
   TS
CP0431511
(S)-2-Hydroxy-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthrene-9-carboxylic acid (2-pyridin-3-yl-ethyl)-amide
   Show/Hide
C27H30N4O2
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0485949
ethyl 2-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]acetate
   Show/Hide
C22H28O4
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0140149
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]thiophene-2-sulfonamide
   Show/Hide
C26H19NO4S2
 1
1
IC50 = 316 nM
   TI
   LI
   LO
   TS
CP0485951
(8R,9S,13S,14S,16R)-16-(ethoxymethyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
   Show/Hide
C21H28O3
 1
1
IC50 = 320 nM
   TI
   LI
   LO
   TS
CP0044042
(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-one
   Show/Hide
C18H22O2
 1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0508224
(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-6,17-dione
   Show/Hide
C18H20O3
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0309110
(2,5-dihydroxyphenyl)-(6-hydroxy-1,3-benzothiazol-2-yl)methanone
   Show/Hide
C14H9NO4S
 1
1
IC50 = 365 nM
   TI
   LI
   LO
   TS
CP0288171
[5-(3-ethyl-4-hydroxyphenyl)thiophen-2-yl]-(3-hydroxyphenyl)methanone
   Show/Hide
C19H16O3S
 1
1
IC50 = 367 nM
   TI
   LI
   LO
   TS
CP0371776
2-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(oxolan-2-ylmethyl)acetamide
   Show/Hide
C25H33NO4
 1
1
IC50 = 380 nM
   TI
   LI
   LO
   TS
CP0154261
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-3-nitrobenzenesulfonamide
   Show/Hide
C28H20N2O6S
 1
1
IC50 = 396 nM
   TI
   LI
   LO
   TS
CP0142664
3-cyano-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C29H20N2O4S
 1
1
IC50 = 402 nM
   TI
   LI
   LO
   TS
CP0163984
2-fluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H20FNO4S
 1
1
IC50 = 429 nM
   TI
   LI
   LO
   TS
CP0465441
3-[[(8R,9S,13S,14S,16R,17S)-3-(bromomethyl)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]methyl]benzamide
   Show/Hide
C27H32BrNO2
 1
1
IC50 = 430 nM
   TI
   LI
   LO
   TS
CP0306868
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-3-methylbenzenesulfonamide
   Show/Hide
C29H23NO4S
 1
1
IC50 = 440 nM
   TI
   LI
   LO
   TS
CP0259627
(8R,9S,13S,14S,16R,17S)-16-(3-bromopropyl)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
   Show/Hide
C21H29BrO2
 1
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
CP0515928
2-hydroxy-6a-methyl-5,6,6a,8,10,10a,10b,11-octahydro-4bH-7,8-diaza-pentaleno[2,1-a]phenanthren-12-one
   Show/Hide
C19H20N2O2
 1
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
CP0146863
3-fluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H20FNO4S
 1
1
IC50 = 462 nM
   TI
   LI
   LO
   TS
CP0161103
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-2-nitrobenzenesulfonamide
   Show/Hide
C28H20N2O6S
 1
1
IC50 = 462 nM
   TI
   LI
   LO
   TS
CP0156088
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]quinoline-6-sulfonamide
   Show/Hide
C31H22N2O4S
 1
1
IC50 = 498 nM
   TI
   LI
   LO
   TS
CP0508205
(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-N-(pyridin-3-ylmethyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16-carboxamide
   Show/Hide
C25H30N2O3
 1
1
IC50 = 510 nM
   TI
   LI
   LO
   TS
CP0140151
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-2-methylbenzenesulfonamide
   Show/Hide
C29H23NO4S
 1
1
IC50 = 525 nM
   TI
   LI
   LO
   TS
CP0428063
(S)-8-(2-Methoxy-ethyl)-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthren-2-ol
   Show/Hide
C22H28N2O2
 1
1
IC50 = 530 nM
   TI
   LI
   LO
   TS
CP0202858
4-cyano-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C29H20N2O4S
 1
1
IC50 = 555 nM
   TI
   LI
   LO
   TS
CP0261616
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-4-methylbenzenesulfonamide
   Show/Hide
C29H23NO4S
 1
1
IC50 = 633 nM
   TI
   LI
   LO
   TS
CP0092222
4-fluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H20FNO4S
 1
1
IC50 = 637 nM
   TI
   LI
   LO
   TS
CP0163924
4-bromo-2,5-difluoro-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H18BrF2NO4S
 1
1
IC50 = 646 nM
   TI
   LI
   LO
   TS
CP0120458
6-(3-hydroxyphenyl)-1-(6-methoxypyridin-3-yl)naphthalen-2-ol
   Show/Hide
C22H17NO3
 1
1
IC50 = 670 nM
   TI
   LI
   LO
   TS
CP0244800
3-hydroxy-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H21NO5S
 1
1
IC50 = 701 nM
   TI
   LI
   LO
   TS
CP0448596
3-((S)-2-Hydroxy-6a-methyl-4b,6,6a,10,10a,10b,11,12-octahydro-5H-7,8-diaza-pentaleno[2,1-a]phenanthren-8-yl)-propionitrile
   Show/Hide
C22H25N3O
 1
1
IC50 = 730 nM
   TI
   LI
   LO
   TS
CP0161105
N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]-4-nitrobenzenesulfonamide
   Show/Hide
C28H20N2O6S
 1
1
IC50 = 753 nM
   TI
   LI
   LO
   TS
CP0442107
(S)-2-Hydroxy-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthrene-9-carboxylic acid (pyridin-3-ylmethyl)-amide
   Show/Hide
C26H28N4O2
 1
1
IC50 = 780 nM
   TI
   LI
   LO
   TS
CP0460175
(8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-N-(1-phenylethyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16-carboxamide
   Show/Hide
C27H33NO3
 1
1
IC50 = 810 nM
   TI
   LI
   LO
   TS
CP0436226
(S)-2-Hydroxy-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthrene-9-carboxylic acid (pyridin-2-ylmethyl)-amide
   Show/Hide
C26H28N4O2
 1
1
IC50 = 880 nM
   TI
   LI
   LO
   TS
CP0448595
((S)-2-Hydroxy-6a-methyl-4b,6,6a,10,10a,10b,11,12-octahydro-5H-7,8-diaza-pentaleno[2,1-a]phenanthren-8-yl)-acetic acid methyl ester
   Show/Hide
C22H26N2O3
 1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CP0428019
(S)-9-Hydroxymethyl-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthren-2-ol
   Show/Hide
C20H24N2O2
 1
1
IC50 = 950 nM
   TI
   LI
   LO
   TS
CP0161106
4-hydroxy-N-[3-[2-hydroxy-6-(3-hydroxyphenyl)naphthalen-1-yl]phenyl]benzenesulfonamide
   Show/Hide
C28H21NO5S
 1
1
IC50 = 1009 nM
   TI
   LI
   LO
   TS
CP0877810
(S)-3-Hydroxy-13-methyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthrene-16,17-dione 16-oxime
   Show/Hide
C18H21NO3
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0113994
1-[1-(benzenesulfonyl)indol-4-yl]-6-(3-hydroxyphenyl)naphthalen-2-ol
   Show/Hide
C30H21NO4S
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0371775
2-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-methylacetamide
   Show/Hide
C21H27NO3
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0478012
5-(4-hydroxyphenyl)-2,3-dihydroinden-1-one
   Show/Hide
C15H12O2
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0515068
4-[4-(3-ethyl-4-hydroxyphenyl)phenyl]-2,2-dimethyl-4-oxo-N-(pyridin-3-ylmethyl)butanamide
   Show/Hide
C26H28N2O3
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0445646
(S)-2-Hydroxy-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthrene-9-carboxylic acid ethyl ester
   Show/Hide
C22H26N2O3
 1
1
IC50 = 1850 nM
   TI
   LI
   LO
   TS
CP0926856
3-hydroxy-13-methyl-8,9,11,12,13,14,15,16-octahydro-7H-cyclopenta[a]phenanthrene-6,17-dione dioxime
   Show/Hide
C18H22N2O3
 1
1
IC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0523779
5-(3-ethyl-4-hydroxyphenyl)-2,3-dihydroinden-1-one
   Show/Hide
C17H16O2
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0404830
(S)-2-Hydroxy-6a-methyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthrene-9-carboxylic acid (1-methyl-1H-pyrrol-2-ylmethyl)-amide
   Show/Hide
C26H30N4O2
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0442104
(S)-6a,8-Dimethyl-4b,5,6,6a,8,10,10a,10b,11,12-decahydro-7,8-diaza-pentaleno[2,1-a]phenanthren-2-ol
   Show/Hide
C20H24N2O
 1
1
IC50 = 2750 nM
   TI
   LI
   LO
   TS
CP0427977
5-(3-fluoro-4-hydroxyphenyl)-2,3-dihydroinden-1-one
   Show/Hide
C15H11FO2
 1
1
IC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0433382
4-[4-(3-ethyl-4-hydroxyphenyl)phenyl]-4-oxo-N-(pyridin-3-ylmethyl)butanamide
   Show/Hide
C24H24N2O3
 1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0516372
1-[4-(4-hydroxy-2-methylphenyl)phenyl]ethanone
   Show/Hide
C15H14O2
 1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0525327
1-[4-(4-hydroxyphenyl)phenyl]ethanone
   Show/Hide
C14H12O2
 1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0371771
(8R,9S,13S,14S,16E,17S)-13-methyl-16-(pyridin-4-ylmethylidene)-7,8,9,11,12,14,15,17-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
   Show/Hide
C24H27NO2
 1
1
IC50 = 4100 nM
   TI
   LI
   LO
   TS
CP0427975
2-[6-(3-ethyl-4-hydroxyphenyl)-3-oxo-1,2-dihydroinden-2-yl]-N-(pyridin-3-ylmethyl)acetamide
   Show/Hide
C25H24N2O3
 1
1
IC50 = 4700 nM
   TI
   LI
   LO
   TS
CP0478114
1-(7-hydroxy-9H-fluoren-2-yl)ethanone
   Show/Hide
C15H12O2
 1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0427974
1-[4-(3-ethyl-4-hydroxyphenyl)phenyl]ethanone
   Show/Hide
C16H16O2
 1
1
IC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0427976
6-(3-ethyl-4-methoxyphenyl)-3,4-dihydro-2H-naphthalen-1-one
   Show/Hide
C19H20O2
 1
1
IC50 = 8300 nM
   TI
   LI
   LO
   TS
CP0471274
1-[2-ethyl-4-(4-hydroxyphenyl)phenyl]ethanone
   Show/Hide
C16H16O2
 1
1
IC50 = 9900 nM
   TI
   LI
   LO
   TS
CP0377970
(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-16-carbonitrile
   Show/Hide
C19H21NO2
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0433899
6-(4-hydroxyphenyl)-3,4-dihydro-2H-naphthalen-1-one
   Show/Hide
C16H14O2
 1
1
IC50 = 15600 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0003433
(Arylindolyl)maleimide deriv. 27
   Show/Hide
C21H16N4O2  1
1
GI50 = 2370 nM
   TI
   LI
   LO
   TS
CP0003580
Faridak
   Show/Hide
C21H23N3O2  1
1
IC50 = 6.98 nM
   TI
   LI
   LO
   TS
CP0006369
6-[3-[4-[1-(5-cyanopentyl)indol-3-yl]-1-hydroxy-2,5-dioxopyrrol-3-yl]indol-1-yl]hexanenitrile
   Show/Hide
C32H31N5O3  1
1
GI50 = 4150 nM
   TI
   LI
   LO
   TS
CP0007711
(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-N'-propylprop-2-enehydrazide;2,2,2-trifluoroacetic acid
   Show/Hide
C26H31F3N4O3  1
1
GI50 = 23.9 nM
   TI
   LI
   LO
   TS
CP0008405
(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide
   Show/Hide
C19H22F3N5O2S  1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0010394
1-(2-chlorophenyl)-3-[4-[4-cyano-5-morpholin-4-yl-2-(1H-1,2,4-triazol-5-yl)thiophen-3-yl]phenyl]urea
   Show/Hide
C24H20ClN7O2S  1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
CP0016713
2-[(E)-2-(2,6-dichlorophenyl)ethenyl]-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one
   Show/Hide
C23H21Cl2NO5  1
1
GI50 = 6000 nM
   TI
   LI
   LO
   TS
CP0018072
US10662186, Compound 63
   Show/Hide
C27H32F2N8  1
1
IC50 = 8.62 nM
   TI
   LI
   LO
   TS
CP0019438
8-[3-(1-benzothiophen-2-yl)-5-chloropyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one
   Show/Hide
C21H20ClN3OS  1
1
GI50 = 17920 nM
   TI
   LI
   LO
   TS
CP0019439
8-[3-(1-benzofuran-2-yl)-5-chloropyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one
   Show/Hide
C21H20ClN3O2  1
1
GI50 = 16180 nM
   TI
   LI
   LO
   TS
CP0043589
(13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
   Show/Hide
C32H47F5O3S  1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0064592
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
   Show/Hide
C47H51NO14  1
1
GI50 = 12.5 nM
   TI
   LI
   LO
   TS
CP0071951
(E)-3-[4-[(E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-enyl]phenyl]prop-2-enoic acid
   Show/Hide
C26H20ClFN2O2  1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
CP0139017
2-[10-(2-methoxyethyl)-13-oxa-3,4,6,7,10-pentazatricyclo[7.4.0.02,6]trideca-1(9),2,4,7-tetraen-5-yl]-N-(piperidin-4-ylmethyl)quinolin-8-amine
   Show/Hide
C25H30N8O2  1
1
GI50 = 10800 nM
   TI
   LI
   LO
   TS
CP0168495
ethyl 4-[[2-[2-(4-cyanophenyl)-2-oxoethyl]sulfanylpyrimidin-4-yl]amino]benzoate
   Show/Hide
C22H18N4O3S  1
1
IC50 = 2180 nM
   TI
   LI
   LO
   TS
CP0213915
ethyl 4-[[2-[2-(4-nitrophenyl)-2-oxoethyl]sulfanylpyrimidin-4-yl]amino]benzoate
   Show/Hide
C21H18N4O5S  1
1
IC50 = 8090 nM
   TI
   LI
   LO
   TS
CP0228522
4-[[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]methyl]-N-hydroxybenzamide
   Show/Hide
C28H26FN5O4  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0236214
2-fluoro-N-[2-[4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]phenyl]ethyl]-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzamide
   Show/Hide
C27H23FN4O4  1
1
IC50 = 2140 nM
   TI
   LI
   LO
   TS
CP0239959
[(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]boronic acid
   Show/Hide
C32H48BF5O4S  1
1
IC50 = 6.1 nM
   TI
   LI
   LO
   TS
CP0360699
2-[4-[[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]methyl]phenyl]-N-hydroxyacetamide
   Show/Hide
C29H28FN5O4  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0372634
5-(3-Chloro-furan-2-yl)-3-(4-trifluoromethyl-phenyl)-[1,2,4]oxadiazole
   Show/Hide
C13H6ClF3N2O2  1
1
GI50 = 170 nM
   TI
   LI
   LO
   TS
CP0372681
5-Chloro-2-[5-(3-chloro-furan-2-yl)-[1,2,4]oxadiazol-3-yl]-pyridine
   Show/Hide
C11H5Cl2N3O2  1
1
GI50 = 13000 nM
   TI
   LI
   LO
   TS
CP0392290
5-(3-Chloro-furan-2-yl)-3-(4-chloro-phenyl)-[1,2,4]oxadiazole
   Show/Hide
C12H6Cl2N2O2  1
1
GI50 = 120 nM
   TI
   LI
   LO
   TS
CP0404841
2-[5-(3-Bromo-furan-2-yl)-[1,2,4]oxadiazol-3-yl]-5-chloro-pyridine
   Show/Hide
C11H5BrClN3O2  1
1
GI50 = 380 nM
   TI
   LI
   LO
   TS
CP0417920
1-(3-{[(2S)-2-aminopropanamido]methyl}phenyl)-N-[(2-methoxyphenyl)methyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
   Show/Hide
C23H24F3N5O3  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0421277
4-((+/-)-(1H-imidazol-1-yl)-N-(imidazolyl)-(E)-retinamide
   Show/Hide
C26H32N4O  1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0461497
5-Chloro-2-[5-(3-chloro-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-pyridine
   Show/Hide
C11H5Cl2N3OS  1
1
GI50 = 200 nM
   TI
   LI
   LO
   TS
CP0461507
5-(3-Bromo-furan-2-yl)-3-(4-trifluoromethyl-phenyl)-[1,2,4]oxadiazole
   Show/Hide
C13H6BrF3N2O2  1
1
GI50 = 320 nM
   TI
   LI
   LO
   TS
CP0463588
ethyl 4-[[2-[2-oxo-2-[4-(trifluoromethyl)phenyl]ethyl]sulfanylpyrimidin-4-yl]amino]benzoate
   Show/Hide
C22H18F3N3O3S  1
1
IC50 = 32060 nM
   TI
   LI
   LO
   TS
CP0488026
2-[4-(3-acetylanilino)pyrimidin-2-yl]sulfanyl-1-(4-phenylphenyl)ethanone
   Show/Hide
C26H21N3O2S  1
1
IC50 = 12050 nM
   TI
   LI
   LO
   TS
CP0497086
2-[5-(3-Chloro-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-5-trifluoromethyl-pyridine
   Show/Hide
C12H5ClF3N3OS  1
1
GI50 = 350 nM
   TI
   LI
   LO
   TS
CP0517565
[4-(adamantane-1-carbonylamino)phenyl] sulfamate
   Show/Hide
C17H22N2O4S  1
1
IC50 = 5780 nM
   TI
   LI
   LO
   TS
CP0531331
1-[4-(3-methylphenyl)cyclohexyl]-4-pyridin-3-ylpiperazine
   Show/Hide
C22H29N3  1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0534160
5-[[2,5-diethoxy-4-(methanesulfonamido)phenyl]methylcarbamoylamino]-2-ethoxy-N-[(4-methoxyphenyl)methyl]benzamide
   Show/Hide
C30H38N4O8S  1
1
IC50 = 8310 nM
   TI
   LI
   LO
   TS
CP0553152
[4-(1-adamantylcarbamoyl)-2-chlorophenyl] sulfamate
   Show/Hide
C17H21ClN2O4S  1
1
IC50 = 1040 nM
   TI
   LI
   LO
   TS
CP0558414
2-[4-[[(Z)-3-oxo-3-(10H-phenothiazin-2-yl)prop-1-enyl]amino]phenyl]sulfonylguanidine
   Show/Hide
C22H19N5O3S2  1
1
IC50 = 23700 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma